Form 4 for CRL Charles River Laboratories
Accepted 2021-09-15 00:00:00 ET · period of report 2021-09-13 · accession 0001127602-21-025281 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-15 | 2021-09-13+ | CRL | Girshick Birgit | Corp. Executive VP | S - Sale | $439.98 | -2,425 | 27.6K | -8% | -$1.07M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-13 | S | D | 2 | $441.66 | 30,025 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-13 | S | D | 72 | $442.15 | 29,953 | D | — | — | |
| 3 | Common | Common Stock | 2021-09-13 | S | D | 7 | $442.73 | 29,946 | D | — | — | |
| 4 | Common | Common Stock | 2021-09-14 | S | D | 2,344 | $439.90 | 27,602 | D | — | — |